Salt Lake City Newswire
Comprehensive Real-Time News Feed for Salt Lake City, UT.
Results 1 - 5 of 5 for "u:formkit.com" in Salt Lake City, UT
The abstract, to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference, describes positive findings from non-clinical studies and the Phase I clinical study with YELIVAA , suggesting that YELIVA A may be an effective drug for the treatment of cholangiocarcinoma Of the three cholangiocarcinoma patients in the Phase I study, one patient had a sustained partial response = 20.3 months) and the other two had stable disease YELIVA A is a proprietary, first-in-class, orally-administered sphingosine kinase-2 selective inhibitor, with anti-cancer and anti-inflammatory activities RedHill is pursuing several Phase I/II clinical studies with YELIVA A in the U.S., targeting multiple oncology and inflammatory indications, some of which are supported by National Cancer Institute grants awarded to Apogee Biotechnology and U.S. universities TEL-AVIV, Israel, Jan. 06, 2017 -- ... (more) Comment?
Great Basin Scientific, Inc. , a molecular diagnostics company, today announced it was named a " Best Companies to Work For " in 2016. Great Basin received the first-time recognition from Utah Business Magazine in the medium-sized company category, for companies with 100 to 500 employees. Comment?
SALT LAKE CITY, Nov. 14, 2016 -- Great Basin Scientific , a molecular diagnostics company, today released the following business update on third quarter 2016 performance in a letter to shareholders: There has been a lot of activity at Great Basin over the last quarter, in terms of progress toward reaching company goals for footprint and revenue growth, menu expansion, and the amortization of the 2015 Notes. To help explain what we are delivering and what we're building toward, the following is a summary of Great Basin's business metrics and status: Revenues and Customers Revenues for the third quarter increased 35% year over year, primarily from the sale of two tests, C. diff and Group B Strep. Comment?
Drugmaker Mylan has come under fire for hiking the price of its EpiPen, an epinephrine autoinjector for the treatment of life-threatening allergic reactions, by more than 450% since 2007. A pair of shots now costs around $600. Comment?
Sera Prognostics, Inc., a women's healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer, will present at the upcoming Ladenburg Thalmann 2016 Healthcare Conference. Dr. Critchfield's presentation will take place at 11:00 AM ET on Tuesday, September 27th, at the Sofitel Hotel in New York. Comment?
- « Previous
- Next »
Copyright © 2017 Topix LLC